Phase 4 Myalgia Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
Polymyalgia Rheumatica
Sanofi300 enrolled9 locationsNCT07286214
Recruiting
Phase 4
Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency
Adrenal InsufficiencyGiant Cell ArteritisPolymyalgia Rheumatica
Marianne Christina Klose250 enrolled3 locationsNCT05435781
Recruiting
Phase 4
Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment
Adrenal InsufficiencyGiant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)
Marianne Andersen100 enrolled3 locationsNCT05193396
Active
Phase 4
A study to determine whether myalgia is due to statin use
Statin-induced myalgia
The George Institue for Global Health15 enrolled1 locationACTRN12616001168448
Completed
Phase 4
Effect of Rocuronium and Sugammadex on Myalgia and Headache After Electro-Convulsive Therapy
Headache after electroconvulsive therapy (ECT)Myalgia after electroconvulsive therapy (ECT)
Gaziantep University48 enrolled1 locationACTRN12613000054718
Not Yet Recruiting
Phase 4
Comparison of 0.5mg/kg and 1.0mg/kg Suxamethonium in patients undergoing Electroconvulsive Therapy (ECT)
the incidence and severity of postprocedure myalgia after ECT comparing two different doses of muscle relaxantcompare the amount of post therapy myalgia between the two dosage groupspatient undergoing voluntary ECT.
Peninsula Health50 enrolled1 locationACTRN12609000072213